C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
01/2005
01/04/2005	US6838459 7-alkyl-and cycloalkyl-substituted imidazotriazinones
01/04/2005	US6838415 Substituted benzoylisoxazoles and the use thereof as herbicides
01/04/2005	US6838193 For use in organic electro-luminescent device that emits white light from current-conducing organic layers
01/04/2005	CA2340999C 5-arylindole derivatives
12/2004
12/30/2004	US20040267009 Reacting a mixture of tris(2-aminoethyl)amine with glyoxal in the presence of water, a water miscible solvent and a tertiary amine with cooling to a temperature of about -30 degrees C. or less, wherein the glyoxal is added slowly to the mixture
12/30/2004	US20040266854 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
12/30/2004	US20040266840 Inhibits replication and/or proliferation of Hepatitis C virus (HCV)
12/30/2004	US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis
12/30/2004	US20040266796 Convergent processes for the synthesis of a GARFT inhibitor containing a methyl substituted thiophene core and intermediates therefor
12/30/2004	US20040266793 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders
12/30/2004	US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta
12/30/2004	US20040266778 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
12/30/2004	US20040266777 Pyridopyrazines and the use thereof as kinase inhibitors
12/30/2004	US20040266756 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines
12/30/2004	US20040266748 Photosensitizing carbamate derivatives
12/30/2004	US20040266742 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease
12/30/2004	US20040265237 oxaliplatin or nedaplatin guest molecule having a cucurbituril derivative as host
12/30/2004	DE10326386A1 N-Heterocyclyl-phenylsubstituierte cyclische Ketoenole N-heterocyclyl-substituted cyclic ketoenols
12/29/2004	WO2004113451A1 Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same
12/29/2004	WO2004113424A1 Method for preparing coprecipitate of substance sparingly soluble in water and polymer soluble in water
12/29/2004	WO2004113344A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
12/29/2004	WO2004113343A1 Tricyclic triazolobenzazepine derivative produced as novel crystalline substance
12/29/2004	WO2004113342A1 Triazolopyrimidines
12/29/2004	WO2004113341A2 Fungicidal triazolopyrimidines
12/29/2004	WO2004113337A1 Convergent synthesis of a garft inhibitor containing a methyl substitute thiophene core and a tetrahydropyrido`2,3-d! pyrimidine ring system and intermediates therefor
12/29/2004	WO2004113335A2 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
12/29/2004	WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/29/2004	WO2004112719A2 Chemical compounds
12/29/2004	WO2004112699A2 Mitotic kinesin inhibitors
12/29/2004	WO2004112480A2 Triazolopyrimidines
12/29/2004	WO2004078714A3 Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazouinoxalines and heterocyclic-substituted imidazopyrazines
12/29/2004	EP1491534A1 Novel hairpin polyamide
12/29/2004	EP1490373A1 Inhibitors of nucleoside phosphorylases and nucleosidases
12/29/2004	EP1490372A1 Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances
12/29/2004	EP1490370A2 Triazolopyrimidines
12/29/2004	EP1490344A2 Anxiolytic agents with reduced sedative and ataxic effects
12/29/2004	EP1490335A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/29/2004	EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
12/29/2004	EP1490057A1 Method for treating cognitive disorders
12/29/2004	EP1248623B1 Treatment of diabetic ulcers
12/29/2004	EP1226138B1 Fab i inhibitors
12/29/2004	EP1066037B1 Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
12/29/2004	EP0869958B1 Novel indole-2,3-dione-3-oxime derivatives
12/29/2004	CN1558934A Water-color ink
12/29/2004	CN1558760A Photodynamic porphyrin antimicrobial agents
12/29/2004	CN1182127C Substituted 2-benzo [c] furanone compound, its preparing process and pharmaceutical composition containing same
12/29/2004	CN1182123C Substituted bicyclic derivatives useful as anticancer agents
12/29/2004	CA2528771A1 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
12/29/2004	CA2527533A1 Mitotic kinesin inhibitors
12/29/2004	CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/28/2004	US6835741 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/28/2004	US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/23/2004	WO2004111058A1 Heteroryl-fused pyrimidinyl compounds as anticancer agents
12/23/2004	WO2004111055A1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
12/23/2004	WO2004111054A1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
12/23/2004	WO2004111053A1 Imidazotriazinone derivatives as pde 7 (phosphodiesterase 7) inhibitors
12/23/2004	WO2004111052A1 Pyrrolopyrimidine derivatives as modulators of multi-drug resistance (mdr)
12/23/2004	WO2004111051A1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments
12/23/2004	WO2004111047A2 Cycloalkanepyrrolopyridines as dp receptor antagonists
12/23/2004	WO2004111042A1 N-heterocyclyl phenyl-substituted cyclic ketoenols
12/23/2004	WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
12/23/2004	WO2004110996A1 Nk1 antagonist
12/23/2004	WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004	WO2004110453A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	WO2004089380A3 Pharmaceutical use of fused 1,2,4-triazoles
12/23/2004	WO2004085409A3 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
12/23/2004	WO2004080958A3 Process to tetrahydrotriazolopyrazines and intermediates
12/23/2004	WO2004076411A3 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
12/23/2004	WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
12/23/2004	WO2004064715A3 Polyhydroxylated pyrrolizidine
12/23/2004	WO2004042002A3 Compounds for modulating rna interference
12/23/2004	WO2004040003A3 Nucleotide-binding protein-directed probes and methods of their synthesis and use
12/23/2004	US20040260086 Catalytic condensation and cyclization of an alpha, beta dialdehyde with an electrophilic primary amine; direct nitration of the hexasubstituted hexanitrohexaazaisowurtsitane derivative; improved efficiency
12/23/2004	US20040259909 using an agonist of alpha 7 nicotinic acetylcholine receptors rather than those of 5HT3 receptors; tropisetron; spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidine-2'-one; N-(1-azabicyclo[2.2.2]oct-3-yl)(3-phenylbenzamide); N-(nitrogen heterocycle)-carboxamides or thiocarboxamides
12/23/2004	US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes
12/23/2004	US20040259887 Cannabinoid receptor ligands and uses thereof
12/23/2004	US20040259870 Antidiabetic agents; obesity; controlling appetite
12/23/2004	US20040259826 Mitotic kinesin inhibitors
12/23/2004	US20040259818 Glucoronide adduct as gaba ligand
12/23/2004	US20040259810 Porphyrin derivatives for photodynamic therapy
12/23/2004	US20040255397 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers
12/23/2004	DE10326137A1 Verfahren zur Erhöhung der Schneidhärte eines Formkörpers enthaltend ein kristallines Alumosilikat und Verwendung dieser Formkörper mit erhöhter Schneidhärte in chemischen Syntheseverfahren, insbesondere in einem Verfahren zur Herstellung von Triethylendiamin (TEDA) durch Umsetzung von Ethylendiamin (EDA) und/oder Piperazin (PIP) Method for increasing the cutting hardness of a molded article comprising a crystalline aluminosilicate and use of these moldings with increased cutting hardness in chemical synthesis, especially in a process for the preparation of triethylene diamine (TEDA) by reaction of ethylenediamine (EDA) and / or piperazine (PIP)
12/23/2004	DE10325133A1 Triazolopyrimidine Triazolopyrimidines
12/23/2004	CA2529729A1 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
12/23/2004	CA2529068A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	CA2528888A1 N-heterocyclylphenyl-substituted cyclic ketoenols
12/23/2004	CA2528652A1 Nk1 antagonist
12/23/2004	CA2527832A1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
12/23/2004	CA2527773A1 Cycloalkanepyrrolopyridines as dp receptor antagonists
12/23/2004	CA2526217A1 Heteroaryl-fused pyrimidinyl compounds as anticancer agents
12/22/2004	EP1489068A1 Multidentate ligand, multi-nucleus metal complex, metal complex chain, metal complex integrated structure, and preparation method thereof
12/22/2004	EP1489061A1 Process for producing cyclic compound
12/22/2004	EP1488793A1 PREVENTIVES OR REMEDIES FOR DISEAES CAUSED BY eNOS EXPRESSION
12/22/2004	EP1487838A2 Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography
12/22/2004	EP1487837A1 An improved process for the production of vasicine
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487797A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
12/22/2004	EP1487450A1 Process for the preparation of antiviral 7-azaindole derivatives
12/22/2004	EP1487449A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
12/22/2004	EP1154990B1 Phthalamide-lanthanide complexes for use as luminescent markers

1 ... 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 ... 573